| Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs RWF Van Leeuwen, DHS Brundel, C Neef, T van Gelder, RHJ Mathijssen, ... British journal of cancer 108 (5), 1071-1078, 2013 | 291 | 2013 |
| Lymph-directed immunotherapy–Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer OM Feeney, G Gracia, DHS Brundel, NL Trevaskis, E Cao, LM Kaminskas, ... Advanced Drug Delivery Reviews 160, 115-135, 2020 | 23 | 2020 |
| Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats IK Styles, OM Feeney, TH Nguyen, DHS Brundel, DW Kang, R Clift, ... Journal of Controlled Release 315, 85-96, 2019 | 17 | 2019 |
| Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability … EJA Suys, DHS Brundel, DK Chalmers, CW Pouton, CJH Porter Journal of Controlled Release 331, 45-61, 2021 | 8 | 2021 |
| Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration DHS Brundel, OM Feeney, CJ Nowell, EJA Suys, G Gracia, ... Nanomedicine 16 (4), 275-292, 2021 | 6 | 2021 |
| Targeting of nanoparticles to tumours with hyaluronidase DHS Brundel Monash University, 2020 | | 2020 |
| Prevalentie van potentiële genees-middelinteracties bij patiënten met kanker, behandeld met orale antikankermiddelen FM de Man, F Piran, DHS Brundel, C Neef, T van Gelder Ned Tijdschr Oncol 11, 133-40, 2014 | | 2014 |
| Drug Interactions in Cancer Patients Treated with Oral Anti-Cancer Drugs RW van Leeuwen, DHS Brundel, C Neef, RHJ Mathijssen, T van Gelder, ... Annals of Oncology 23, ix456, 2012 | | 2012 |
